Company Filing History:
1 out of 832,843 Years Active: 2021
Title: David Swayne: Innovator in Avian Influenza Research
Introduction
David Swayne is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of avian influenza research. His work focuses on developing innovative solutions to combat avian pathogens.
Latest Patents
David Swayne holds a patent for "Recombinant vectors expressing antigens of avian influenza virus and uses thereof." This invention provides recombinant viral vectors that contain and express antigens of avian pathogens. The patent also includes compositions comprising these recombinant viral vectors and polyvalent vaccines. Furthermore, it outlines methods of vaccination against various avian pathogens and the production of the recombinant viral vectors.
Career Highlights
Throughout his career, David Swayne has demonstrated a commitment to advancing the understanding and treatment of avian diseases. His innovative approaches have positioned him as a leader in his field. He continues to contribute valuable insights and research findings that benefit both the scientific community and public health.
Collaborations
David has collaborated with esteemed colleagues such as Teshome Mebatsion and Joyce Pritchard. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
David Swayne's work in avian influenza research exemplifies the importance of innovation in addressing public health challenges. His contributions through patents and collaborations continue to pave the way for advancements in veterinary medicine and disease prevention.